Information from the abstract
Iron deficiency is a common, yet often untreated, comorbidity in patients with a wide range of cardiovascular disease (CVD). As clinical evidence mounts on the benefits of correction of iron deficiency in patients with CVD and the safety and efficacy of iron-replacement therapies, there is a need to elevate the quality of care provided to patients with CVD and iron deficiency in the Asia-Pacific region. Hence, the Asian Pacific Society of Cardiology established a multidisciplinary panel to develop regional consensus recommendations on the management of iron deficiency in patients with CVD. Twenty-one experts from various countries in the region reviewed the available clinical evidence to develop 21 consensus statements for patients with heart failure, cyanotic congenital heart disease, concomitant CVD or chronic kidney disease; those undergoing cardiac surgery or admitted to cardiovascular intensive care; or pregnant women with heart disease.
Why this record is monitored
This record has an Impact Signal of 76/100 based on recency, source, collaboration, and bibliographic signals. It prioritizes monitoring and is not a judgment of research quality.
Related topics: Erythropoietin and Anemia Treatment · Iron Metabolism and Disorders · Heart Failure Treatment and Management
Thai researcher and institutional participation
Talerngsak Kanjanabuch · Chulalongkorn University
Data limitations
This page is a bibliographic record based on abstract-level information, not a full analysis or quality assessment. Verify the DOI and original article before citation.